Author Correction: Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors

Affiliations

• ¹ Department Immunology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
• ² Department of Molecular Pharmacology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
• ³ Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
• ⁴ Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York, USA.
• ⁵ Department of Immunology, University of Toronto, Sunnybrook Research Institute, Toronto, Ontario, Canada.
• ⁶ Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, Gainesville, Florida, USA.
• ⁷ Department Immunology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. [email protected].
• ⁸ Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. [email protected].